Literature DB >> 28364392

Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.

Libor Fila1, Pavel Dřevínek2.   

Abstract

Cystic fibrosis (CF) patients in the Czech Republic suffered in the late 1990s from an epidemic with ST32 strain of Burkholderia cepacia complex (Bcc). Cohort segregation of Bcc and of ST32 positive patients was introduced in 1999 and 2002, respectively. We performed a study to evaluate the molecular epidemiology of Bcc infection after implementation of these infection control measures. Patients attending the Prague CF adult Centre from 2000 to 2015 were included in the present study. Demographic data and microbial statuses were collected from patient records. All Bcc isolates were analyzed using multilocus sequence typing (MLST). The prevalences of epidemic strain ST32 and of other Bcc strains were calculated. Ninety out of 227 CF patients were infected with Bcc during the study period. The prevalence of ST32 cases significantly decreased from 46.5% in 2000-2001 to 10.4% in 2014-2015 (P < 0.001) due to occurrence of only one new case in 2003, as well as to the death of 72% of ST32-infected patients. Conversely, there was a significant increase in prevalence of other Bcc strains, which rose from 0 to 14.9% (P = 0.015) and of transient infections. A micro-epidemic of infection with ST630 strain was observed in 2014 in lung transplant patients hospitalized in intensive care unit. The prevalence of epidemic strain ST32 decreased, whereas that of non-clonal strains of Bcc increased. Routine use of MLST allowed early detection of new and potentially epidemic strains.

Entities:  

Keywords:  Cystic Fibrosis; Cystic Fibrosis Patient; Molecular Genetic Method; Multilocus Sequence Typing; recA Group

Mesh:

Year:  2017        PMID: 28364392     DOI: 10.1007/s12223-017-0523-x

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  28 in total

1.  Genomovar distribution of the Burkholderia cepacia complex differs significantly between Czech and Slovak patients with cystic fibrosis.

Authors:  Pavel Drevinek; Ondrej Cinek; Jan Melter; Leon Langsadl; Yveta Navesnakova; Vera Vavrova
Journal:  J Med Microbiol       Date:  2003-07       Impact factor: 2.472

2.  Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Kathleen M Thickett; David Honeybourne; Martin C J Maiden; John R Govan; David P Speert; John J Lipuma; Peter Vandamme; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.

Authors:  Mónica V Cunha; Ana Pinto-de-Oliveira; Luís Meirinhos-Soares; Maria José Salgado; José Melo-Cristino; Susana Correia; Celeste Barreto; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

Review 4.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

5.  Infection prevention and control guideline for cystic fibrosis: 2013 update.

Authors:  Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-01       Impact factor: 3.254

6.  Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.

Authors:  A Agodi; E Mahenthiralingam; M Barchitta; V Gianninò; A Sciacca; S Stefani
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

7.  Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic.

Authors:  Pavel Drevinek; Sarka Vosahlikova; Ondrej Cinek; Vera Vavrova; Jana Bartosova; Petr Pohunek; Eshwar Mahenthiralingam
Journal:  J Med Microbiol       Date:  2005-07       Impact factor: 2.472

Review 8.  Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.

Authors:  E Mahenthiralingam; A Baldwin; C G Dowson
Journal:  J Appl Microbiol       Date:  2008-01-24       Impact factor: 3.772

9.  Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina.

Authors:  Pablo Martina; Marisa Bettiol; Cecilia Vescina; Patricia Montanaro; M Constanza Mannino; Claudia I Prieto; Carlos Vay; Dieter Naumann; Juergen Schmitt; Osvaldo Yantorno; Antonio Lagares; Alejandra Bosch
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

View more
  1 in total

1.  What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics.

Authors:  Jaroslav Nunvar; Vaclav Capek; Karel Fiser; Libor Fila; Pavel Drevinek
Journal:  PLoS Pathog       Date:  2017-12-11       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.